Predictive value of soluble CD59 for poor 28-day neurological prognosis and all-cause mortality in patients after cardiopulmonary resuscitation: a prospective observatory study.

"Declarations Ethics approval and consent to participateThe study protocol was approved by the Medical Ethics Committee of the First Affiliated Hospital of Dalian Medical University (PJ-KS-KY-2019-150), and was carried out in accordance with Good Clinical Practice guidelines and the Declaration of Helsinki (2013 edition) adopted by the World Medical Association. Written informed consent was obtained from all patients (or their relatives) upon their initial admission to hospital and from healthy volunteers. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study was funded by Shenzhen Key Medical Discipline Construction Fund (SZXK046) and the National Nature Science Foundation of China (81571869)."